Insurance Card  (Photo: Shutterstock)

Several patient groups are challenging a federal rule that allows health insurers to avoid counting the value of drug manufacturer copay assistance toward patients’ out-of-pocket cost obligations. The HIV+Hepatitis Policy Institute, the Diabetes Leadership Council and the Diabetes Patient Advocacy Coalition filed suit in the U.S. District Court for the District of Columbia in late August.

Insurers and pharmacy benefit managers have instituted policies that do not apply copay assistance toward beneficiaries’ out-of-pocket costs and deductibles, according to the plaintiffs. These policies, often are referred to as “copay accumulator adjustment programs,” allow the insurer to divert the benefit of the assistance away from the patient to the plan. They then require the patient to pay that amount again before meeting their deductible and other out-of-pocket cost obligations.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.